Foghorn Therapeutics (FHTX) Other Gross PP&E Adjustments (2020 - 2025)
Historic Other Gross PP&E Adjustments for Foghorn Therapeutics (FHTX) over the last 6 years, with Q3 2025 value amounting to $16.1 million.
- Foghorn Therapeutics' Other Gross PP&E Adjustments rose 199791.12% to $16.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $16.1 million, marking a year-over-year increase of 199791.12%. This contributed to the annual value of -$1.5 million for FY2024, which is 8549.92% up from last year.
- Per Foghorn Therapeutics' latest filing, its Other Gross PP&E Adjustments stood at $16.1 million for Q3 2025, which was up 199791.12% from $15.4 million recorded in Q2 2025.
- In the past 5 years, Foghorn Therapeutics' Other Gross PP&E Adjustments registered a high of $22.0 million during Q1 2021, and its lowest value of -$18.0 million during Q2 2021.
- In the last 5 years, Foghorn Therapeutics' Other Gross PP&E Adjustments had a median value of -$6.7 million in 2023 and averaged -$4.4 million.
- As far as peak fluctuations go, Foghorn Therapeutics' Other Gross PP&E Adjustments plummeted by 16517.66% in 2022, and later surged by 199791.12% in 2025.
- Foghorn Therapeutics' Other Gross PP&E Adjustments (Quarter) stood at -$17.0 million in 2021, then grew by 22.15% to -$13.3 million in 2022, then rose by 24.35% to -$10.0 million in 2023, then soared by 85.5% to -$1.5 million in 2024, then surged by 1205.23% to $16.1 million in 2025.
- Its Other Gross PP&E Adjustments was $16.1 million in Q3 2025, compared to $15.4 million in Q2 2025 and $5.0 million in Q1 2025.